CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
210 hedge funds and large institutions have $2.47B invested in Clovis Oncology, Inc. in 2018 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 89 increasing their positions, 57 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
8% less funds holding
Funds holding: 229 → 210 (-19)
40% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 42
Holders
210
Holding in Top 10
5
Calls
$145M
Puts
$46.7M
Top Buyers
| 1 | +$106M | |
| 2 | +$80M | |
| 3 | +$46.3M | |
| 4 |
BlackRock
New York
|
+$25.6M |
| 5 |
PC
PointState Capital
New York
|
+$22.9M |
Top Sellers
| 1 | -$45.1M | |
| 2 | -$17.3M | |
| 3 | -$16.3M | |
| 4 |
SC
Samlyn Capital
New York
|
-$16.3M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$14.3M |